Lumos Diagnostics Holdings Ltd

Research Lumos Diagnostics Holdings Ltd (LDX) on Bullrun: market cap AUD 101.63M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLDX
• ExchangeAU
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyAUD
• Market capAUD 101.63M
• Financial periodFY2025
• RevenueAUD 12.50M
• Revenue growth12.3%
• Net income-AUD 7.18M
• Free cash flow-AUD 9.39M
• Gross margin63.2%

Valuation Snapshot

latest market cap is AUD 101.63M.

About Lumos Diagnostics Holdings Ltd

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19.

Frequently asked questions

What is Lumos Diagnostics Holdings Ltd's market cap?

Lumos Diagnostics Holdings Ltd's market capitalization is AUD 101.63M.

What does Lumos Diagnostics Holdings Ltd do?

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States.